Thomas Tobin

3.2k total citations · 1 hit paper
141 papers, 2.4k citations indexed

About

Thomas Tobin is a scholar working on Molecular Biology, Pharmacology and Animal Science and Zoology. According to data from OpenAlex, Thomas Tobin has authored 141 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 40 papers in Pharmacology and 39 papers in Animal Science and Zoology. Recurrent topics in Thomas Tobin's work include Pharmacological Effects and Assays (30 papers), Hormonal and reproductive studies (24 papers) and Veterinary Pharmacology and Anesthesia (23 papers). Thomas Tobin is often cited by papers focused on Pharmacological Effects and Assays (30 papers), Hormonal and reproductive studies (24 papers) and Veterinary Pharmacology and Anesthesia (23 papers). Thomas Tobin collaborates with scholars based in United States, Canada and Brazil. Thomas Tobin's co-authors include Robert L. Post, Amar K. Sen, Tai Akera, A. K. Sen, Shoko Kume, Theodore M. Brody, J. W. Blake, W.E. Woods, Andreas F. Lehner and J.D. Harkins and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Thomas Tobin

133 papers receiving 2.2k citations

Hit Papers

Flexibility of an Active Center in Sodium-Plus-Potassium ... 1969 2026 1988 2007 1969 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Tobin United States 23 1.1k 373 373 341 310 141 2.4k
Cornelius E. Uboh United States 27 427 0.4× 253 0.7× 375 1.0× 277 0.8× 328 1.1× 84 2.0k
H. Richard Adams United States 27 676 0.6× 221 0.6× 99 0.3× 297 0.9× 76 0.2× 100 2.6k
Fuyu Guan United States 24 285 0.3× 82 0.2× 342 0.9× 151 0.4× 100 0.3× 68 1.4k
Ove Svendsen Denmark 22 365 0.3× 183 0.5× 339 0.9× 176 0.5× 24 0.1× 59 1.9k
Giulio Soldani Italy 24 331 0.3× 177 0.5× 79 0.2× 435 1.3× 64 0.2× 104 1.7k
Gary L. Henderson United States 27 592 0.5× 116 0.3× 90 0.2× 226 0.7× 8 0.0× 63 2.4k
Yvan Gaillard France 23 281 0.2× 84 0.2× 170 0.5× 234 0.7× 11 0.0× 86 1.7k
T. Taylor United States 23 109 0.1× 242 0.6× 136 0.4× 196 0.6× 307 1.0× 75 1.1k
W. Meuldermans Belgium 30 590 0.5× 195 0.5× 65 0.2× 432 1.3× 7 0.0× 70 2.8k
Wenjuan S. Jobgen United States 11 506 0.4× 59 0.2× 297 0.8× 50 0.1× 17 0.1× 15 1.9k

Countries citing papers authored by Thomas Tobin

Since Specialization
Citations

This map shows the geographic impact of Thomas Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Tobin more than expected).

Fields of papers citing papers by Thomas Tobin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Tobin. The network helps show where Thomas Tobin may publish in the future.

Co-authorship network of co-authors of Thomas Tobin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Tobin. A scholar is included among the top collaborators of Thomas Tobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Tobin. Thomas Tobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brewer, Kimberly, et al.. (2024). 20-Hydroxyecdysone identification in performance horses – case reports and review. Pferdeheilkunde Equine Medicine. 40(1). 10–17.
2.
Brewer, Kimberly, et al.. (2022). Sporadic worldwide “clusters” of feed driven Zilpaterol identifications in racing horses: a review and analysis. Irish Veterinary Journal. 75(1). 11–11. 1 indexed citations
3.
Pusterla, Nicola & Thomas Tobin. (2017). Therapeutics for Equine Protozoal Myeloencephalitis. Veterinary Clinics of North America Equine Practice. 33(1). 87–97. 3 indexed citations
4.
Lehner, Andreas F., et al.. (2011). Evaluation of Mass Spectrometric Methods for Detection of the Anti-Protozoal Drug Imidocarb. Journal of Analytical Toxicology. 35(4). 199–204. 7 indexed citations
5.
Dirikolu, Levent, et al.. (2011). Toltrazuril sulfone sodium salt: synthesis, analytical detection, and pharmacokinetics in the Horse. Journal of Veterinary Pharmacology and Therapeutics. 35(3). 265–274. 5 indexed citations
6.
Dirikolu, Levent, Andreas F. Lehner, J.D. Harkins, et al.. (2009). Pyrilamine in the horse: detection and pharmacokinetics of pyrilamine and its major urinary metaboliteO‐desmethylpyrilamine. Journal of Veterinary Pharmacology and Therapeutics. 32(1). 66–78. 7 indexed citations
7.
Camargo, Fernanda Carolina, Nicola Robinson, Levent Dirikolu, et al.. (2008). Plasma and urinary concentrations of trimetoquinol by LC‐MS‐MS following intravenous and intra‐tracheal administration to horses with heaves. Journal of Veterinary Pharmacology and Therapeutics. 31(6). 501–510. 1 indexed citations
8.
Dirikolu, Levent, et al.. (2003). Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.. PubMed. 4(4). 350–63. 5 indexed citations
9.
Dirikolu, Levent, et al.. (2003). A Simple and Highly Sensitive Spectrophotometric Method for the Determination of Cyanide in Equine Blood. Toxicology Mechanisms and Methods. 13(2). 129–138. 22 indexed citations
10.
Queiroz‐Neto, A., et al.. (2002). Determination of the highest no‐effect dose (HNED) and of the elimination pattern for cocaine in horses. Journal of Applied Toxicology. 22(2). 117–121. 5 indexed citations
11.
Harkins, J.D., et al.. (2001). Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation. Journal of Veterinary Pharmacology and Therapeutics. 24(2). 89–98. 8 indexed citations
12.
Queiroz‐Neto, A., et al.. (2001). Effects of caffeine on locomotor activity of horses: determination of the no‐effect threshold. Journal of Applied Toxicology. 21(3). 229–234. 12 indexed citations
13.
Hawkins, J. D., William A. Rees, George D. Mundy, Scott D. Stanley, & Thomas Tobin. (1998). An overview of the methylxanthines and their regulation in the horse. Equine practice. 20(1). 10–16. 11 indexed citations
14.
Harkins, J.D., George D. Mundy, S. Stanley, et al.. (1996). Determination of highest no effect dose (HNED) for local anaesthetic responses to procaine, cocaine, bupivacaine and benzocaine. Equine Veterinary Journal. 28(1). 30–37. 23 indexed citations
15.
Stanley, S., W.E. Woods, H H Tai, et al.. (1991). Morphine and Etorphine: XIV. Detection by ELISA in Equine Urine*. Journal of Analytical Toxicology. 15(6). 305–310. 8 indexed citations
16.
Weckman, T J, et al.. (1989). Pharmacologic effects and detection methods of methylated analogs of fentanyl in horses. American Journal of Veterinary Research. 50(4). 502–507. 8 indexed citations
17.
Weckman, T J, et al.. (1988). Radioimmunoassay for etorphine in horses with a 125I analog of etorphine. American Journal of Veterinary Research. 49(5). 622–628. 3 indexed citations
18.
Soma, Lawrence R., Richard A. Sams, Wayne C. Duer, et al.. (1985). Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens. American Journal of Veterinary Research. 46(4). 932–938. 13 indexed citations
20.
Post, Robert L., et al.. (1969). Flexibility of an Active Center in Sodium-Plus-Potassium Adenosine Triphosphatase. The Journal of General Physiology. 54(1). 306–326. 379 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026